Literature DB >> 11474663

Glanders in a military research microbiologist.

A Srinivasan1, C N Kraus, D DeShazer, P M Becker, J D Dick, L Spacek, J G Bartlett, W R Byrne, D L Thomas.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11474663     DOI： 10.1056/NEJM200107263450404

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  82 in total

1.  Surge capacity for response to bioterrorism in hospital clinical microbiology laboratories.

Authors:  Daniel S Shapiro
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

2.  Preliminary evaluation of the API 20NE and RapID NF plus systems for rapid identification of Burkholderia pseudomallei and B. mallei.

Authors:  Mindy B Glass; Tanja Popovic
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

Review 3.  Current and developing technologies for monitoring agents of bioterrorism and biowarfare.

Authors:  Daniel V Lim; Joyce M Simpson; Elizabeth A Kearns; Marianne F Kramer
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

4.  Use of a recombinant burkholderia intracellular motility a protein for immunodiagnosis of glanders.

Authors:  Subodh Kumar; Praveen Malik; Shailendra Kumar Verma; Vijai Pal; Vandana Gautam; Chiranjay Mukhopadhyay; Ganga Prasad Rai
Journal:  Clin Vaccine Immunol       Date:  2011-07-13

Review 5.  Evidence-based biosafety: a review of the principles and effectiveness of microbiological containment measures.

Authors:  Tjeerd G Kimman; Eric Smit; Michèl R Klein
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

6.  Bacteriophage-associated genes responsible for the widely divergent phenotypes of variants of Burkholderia pseudomallei strain MSHR5848.

Authors:  David DeShazer; Sean Lovett; Joshua Richardson; Galina Koroleva; Kathleen Kuehl; Kei Amemiya; Mei Sun; Patricia Worsham; Susan Welkos
Journal:  J Med Microbiol       Date:  2019-01-10       Impact factor: 2.472

7.  Burkholderia mallei cluster 1 type VI secretion mutants exhibit growth and actin polymerization defects in RAW 264.7 murine macrophages.

Authors:  Mary N Burtnick; David DeShazer; Vinod Nair; Frank C Gherardini; Paul J Brett
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

8.  Protection from pneumonic infection with burkholderia species by inhalational immunotherapy.

Authors:  Andrew Goodyear; Lisa Kellihan; Helle Bielefeldt-Ohmann; Ryan Troyer; Katie Propst; Steven Dow
Journal:  Infect Immun       Date:  2009-01-29       Impact factor: 3.441

9.  Mechanism and inhibition of the FabV enoyl-ACP reductase from Burkholderia mallei.

Authors:  Hao Lu; Peter J Tonge
Journal:  Biochemistry       Date:  2010-02-16       Impact factor: 3.162

Review 10.  Strategies toward vaccines against Burkholderia mallei and Burkholderia pseudomallei.

Authors:  Sara K Bondi; Joanna B Goldberg
Journal:  Expert Rev Vaccines       Date:  2008-11       Impact factor: 5.217
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.